“Roy has built a strong foundation, enhanced financial resilience and created an impact-driven culture with a highly engaged team focused on delivering better care for more people through meaningful innovation. Since his start, significant progress has been made in addressing the Respironics recall and continuing to improve Philips’ culture of patient safety and quality. Supply chain operations are resilient and adaptive as evidenced by the company’s management of tariffs. The organization is simpler, leaner and more agile with EUR 2.5 billion productivity savings achieved. The senior leadership team is renewed, and the culture focused on performance, growth, execution and innovation. Company growth is restored, margins materially increased and positive cash generation resulted in a robust balance sheet. The Supervisory Board is confident that Roy is the right leader to continue guiding Philips with ongoing focus and accountability to create long-term sustainable value for all stakeholders.”